Shares of Merrimack Pharmaceuticals rose by a staggering 21.25% in 14 days from $28.84 to $7.59 at 15:22 EST on Wednesday, following last session’s downward trend. NASDAQ Composite is rising 0.72% to $13,885.76, after two consecutive sessions in a row of losses. This seems, up to now, a somewhat positive trend trading session today.

Merrimack Pharmaceuticals’s last close was $7.58, 24.51% below its 52-week high of $9.45.

Merrimack Pharmaceuticals’s Stock Yearly Top and Bottom Value

Merrimack Pharmaceuticals’s stock is valued at $7.59 at 15:22 EST, way below its 52-week high of $9.45 and way above its 52-week low of $2.97.

Merrimack Pharmaceuticals’s Moving Average

Merrimack Pharmaceuticals’s value is way above its 50-day moving average of $6.88 and way higher than its 200-day moving average of $5.87.

More news about Merrimack Pharmaceuticals.


Please enter your comment!
Please enter your name here